A detailed history of Parallel Advisors, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Parallel Advisors, LLC holds 12,422 shares of RDY stock, worth $990,157. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,422
Previous 10,952 13.42%
Holding current value
$990,157
Previous $803,000 17.81%
% of portfolio
0.02%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$68.26 - $76.19 $100,342 - $111,999
1,470 Added 13.42%
12,422 $946,000
Q1 2024

May 06, 2024

BUY
$67.36 - $77.59 $298,943 - $344,344
4,438 Added 68.13%
10,952 $803,000
Q4 2023

Feb 09, 2024

BUY
$64.27 - $69.9 $24,229 - $26,352
377 Added 6.14%
6,514 $453,000
Q3 2023

May 20, 2024

BUY
$61.9 - $72.77 $106,653 - $125,382
1,723 Added 39.03%
6,137 $410,000
Q3 2023

Nov 13, 2023

BUY
$61.9 - $72.77 $106,653 - $125,382
1,723 Added 39.03%
6,137 $410,000
Q2 2023

May 20, 2024

BUY
$53.34 - $63.11 $10,934 - $12,937
205 Added 4.87%
4,414 $278,000
Q2 2023

Aug 04, 2023

BUY
$53.34 - $63.11 $10,934 - $12,937
205 Added 4.87%
4,414 $278,000
Q1 2023

May 20, 2024

SELL
$51.63 - $56.93 $348,141 - $383,878
-6,743 Reduced 61.57%
4,209 $239,000
Q1 2023

Apr 25, 2023

BUY
$51.63 - $56.93 $59,064 - $65,127
1,144 Added 37.32%
4,209 $239,000
Q4 2022

Feb 03, 2023

SELL
$51.15 - $57.45 $127,158 - $142,820
-2,486 Reduced 44.78%
3,065 $158,000
Q3 2022

Nov 10, 2022

BUY
$49.9 - $57.32 $52,644 - $60,472
1,055 Added 23.47%
5,551 $291,000
Q2 2022

Aug 01, 2022

BUY
$49.62 - $58.13 $30,665 - $35,924
618 Added 15.94%
4,496 $249,000
Q1 2022

Apr 28, 2022

BUY
$48.27 - $65.25 $14,191 - $19,183
294 Added 8.2%
3,878 $220,000
Q4 2021

Jan 20, 2022

SELL
$59.5 - $67.25 $14,875 - $16,812
-250 Reduced 6.52%
3,584 $234,000
Q3 2021

Nov 02, 2021

BUY
$60.19 - $75.29 $3,430 - $4,291
57 Added 1.51%
3,834 $250,000
Q2 2021

Aug 06, 2021

BUY
$62.12 - $74.2 $12,424 - $14,840
200 Added 5.59%
3,777 $278,000
Q1 2021

Apr 23, 2021

SELL
$57.98 - $73.08 $1,565 - $1,973
-27 Reduced 0.75%
3,577 $220,000
Q4 2020

Feb 02, 2021

SELL
$62.61 - $71.29 $29,364 - $33,435
-469 Reduced 11.51%
3,604 $257,000
Q3 2020

Oct 27, 2020

BUY
$51.39 - $72.41 $4,984 - $7,023
97 Added 2.44%
4,073 $283,000
Q2 2020

Jul 16, 2020

SELL
$39.55 - $54.65 $31,442 - $43,446
-795 Reduced 16.66%
3,976 $210,000
Q1 2020

Apr 27, 2020

BUY
$34.75 - $45.85 $68,179 - $89,957
1,962 Added 69.85%
4,771 $192,000
Q4 2019

Jan 30, 2020

BUY
$36.66 - $41.78 $36,696 - $41,821
1,001 Added 55.37%
2,809 $114,000
Q3 2019

Nov 01, 2019

BUY
$34.82 - $39.26 $18,454 - $20,807
530 Added 41.47%
1,808 $68,000
Q2 2019

Aug 05, 2019

BUY
$36.05 - $42.76 $8,399 - $9,963
233 Added 22.3%
1,278 $48,000
Q1 2019

May 01, 2019

BUY
$35.77 - $40.57 $23,643 - $26,816
661 Added 172.14%
1,045 $42,000
Q4 2018

Feb 05, 2019

BUY
$31.89 - $38.44 $2,104 - $2,537
66 Added 20.75%
384 $14,000
Q3 2018

Nov 01, 2018

SELL
$29.25 - $36.73 $1,462 - $1,836
-50 Reduced 13.59%
318 $11,000
Q2 2018

Jul 30, 2018

BUY
$28.49 - $35.06 $5,783 - $7,117
203 Added 123.03%
368 $11,000
Q1 2018

May 08, 2018

SELL
$31.93 - $39.54 $8,940 - $11,071
-280 Reduced 62.92%
165 $5,000
Q4 2017

Feb 13, 2018

BUY
$34.15 - $37.62 $12,703 - $13,994
372 Added 509.59%
445 $17,000
Q3 2017

Nov 15, 2017

BUY
$30.11 - $37.72 $2,198 - $2,753
73 New
73 $3,000
Q3 2017

Nov 14, 2017

SELL
$30.11 - $37.72 $8,882 - $11,127
-295 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
295
295 $11,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $13.2B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.